Close Menu
  • Home
  • Finance News
  • Personal Finance
  • Investing
  • Cards
    • Credit Cards
    • Debit
  • Insurance
  • Loans
  • Mortgage
  • More
    • Save Money
    • Banking
    • Taxes
    • Crime
What's Hot

Can You Still Get Social Security If You Move Abroad?

July 11, 2025

What to know about flash floods and homeowners insurance

July 11, 2025

Fed mulls smaller role for governance in supervisory ratings

July 11, 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
Smart SpendingSmart Spending
Subscribe
  • Home
  • Finance News
  • Personal Finance
  • Investing
  • Cards
    • Credit Cards
    • Debit
  • Insurance
  • Loans
  • Mortgage
  • More
    • Save Money
    • Banking
    • Taxes
    • Crime
Smart SpendingSmart Spending
Home»Finance News»Stocks making the biggest moves premarket: AMGN, BBY, ANF, STLA
Finance News

Stocks making the biggest moves premarket: AMGN, BBY, ANF, STLA

November 29, 2024No Comments3 Mins Read
Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
Stocks making the biggest moves premarket: AMGN, BBY, ANF, STLA
Share
Facebook Twitter LinkedIn Pinterest Email

Check out the companies making headlines before the bell: Abercrombie & Fitch — Shares slipped nearly 4% despite the apparel retailer’s earnings beat and strong holiday guidance . Abercrombie & Fitch reported third-quarter earnings of $2.50 per share, topping the $2.39 per share LSEG consensus estimate. Revenue was $1.21 billion, versus the $1.19 billion expected. The company also raised its full-year guidance. Best Buy — Shares slid 7.4% after Best Buy posted third-quarter results that missed analysts’ expectations and cut its full-year sales forecast. Adjusted earnings of $1.26 per share came in below the estimate of $1.29 in earnings per share expected by analysts polled by LSEG. Revenue of $9.45 billion missed the $9.63 billion consensus estimate. Kohl’s — Shares plummeted nearly 17% following the retailer’s weaker-than-expected third-quarter earnings. Kohl’s earned 20 cents per share on revenue of $3.51 billion for the period, while analysts surveyed by LSEG had penciled in 28 cents per share on $3.64 billion in revenue. Stellantis — Shares of European and Japanese automakers slid after President-elect Donald Trump said in a Truth Social post on Monday that he plans to raise tariffs on products from China, Mexico and Canada. Many carmakers have factories in Mexico. Stellantis, which is considering revising its plan to expand manufacturing into Mexico, saw shares dip more than 3.5% on the news. Automakers General Motors and Ford Motor also edged more than 4% and 2%, respectively. Dick’s Sporting Goods — Shares of the sporting goods retailer jumped 6.6% after the company’s quarterly results beat expectations and indicated a strong holiday shopping season outlook. Dick’s raised its full-year guidance and said it now expects fiscal 2024 same-store sales to grow between 3.6% and 4.2%, up from a previous range of 2.5% to 3.5%. Zoom Communications — Shares slipped roughly 10.5% after the video software maker gave fiscal fourth-quarter adjusted earnings per share guidance that was roughly in line with estimates. Zoom exceeded Wall Street’s profit and revenue estimates for its fiscal third quarter, however. Amgen — Shares fell more than 3% after the company said its experimental weight loss drug helped patients lose up to 20% of their weight after a year. However, those trial results appeared to be on the low end of investor expectations. Rivian Automotive — Shares of the electric vehicle maker rose about 9% after the company said it received conditional approval for a government loan of up to $6.6 billion to support its production capacity, including the construction of its Georgia EV plant. Fluence Energy — The energy storage stock fell about 4% after the company’s fourth-quarter revenue missed expectations. Fluence reported $1.23 billion in revenue for the quarter, below the $1.28 billion expected by analysts, according to FactSet. Earnings per share of 34 cents was ahead of the 28 cents per share expected by analysts. Novo Nordisk , Eli Lilly — Shares of drugmakers Novo Nordisk and Eli Lilly rose more than 2.5% and 4.7%, respectively, after the Biden administration proposed a new rule that Medicare and Medicaid would cover costly weight loss drugs for Americans with obesity . Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound weekly injectables treat obesity. — CNBC’s Sarah Min, Sean Conlon, Fred Imbert, Jesse Pound and Michelle Fox Theobald contributed reporting.

See also  What stagflation may mean for your money

Source link

AMGN ANF BBY Biggest Making Moves premarket STLA stocks
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
Previous Article9 types of business loans
Next Article No, Gen Z Is Not ‘Drowning In Debt’ More Than Other Generations

Related Posts

What to know about flash floods and homeowners insurance

July 11, 2025

Fed considering changes to what constitutes a ‘well-managed’ bank

July 11, 2025

Trump’s ‘big beautiful bill’ ends $7,500 EV tax credit

July 10, 2025
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Vital tips for keeping your New Year’s resolution in 2025!

December 30, 2024

Mortgage Digest: MPC National Conference edition

October 31, 2024

Redfin Expects Flat Mortgage Rates, Falling Home Prices for Remainder of 2025

May 29, 2025
Ads Banner

Subscribe to Updates

Subscribe to Get the Latest Financial Tips and Insights Delivered to Your Inbox!

Stay informed with our finance blog! Get expert insights, money management tips, investment strategies, and the latest financial news to help you make smart financial decisions.

We're social. Connect with us:

Facebook X (Twitter) Instagram YouTube
Top Insights

Can You Still Get Social Security If You Move Abroad?

July 11, 2025

What to know about flash floods and homeowners insurance

July 11, 2025

Fed mulls smaller role for governance in supervisory ratings

July 11, 2025
Get Informed

Subscribe to Updates

Subscribe to Get the Latest Financial Tips and Insights Delivered to Your Inbox!

© 2025 Smartspending.ai - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.